Annual report pursuant to Section 13 and 15(d)

Description of Business (Details Narrative)

v3.23.1
Description of Business (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 25, 2021
Jun. 09, 2021
Sep. 30, 2021
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]        
Fair market value of common stock       $ 50,084
Risk free rate   0.84%    
Volatility rate   250.00%    
Exit period   5 years    
Discount rate   35.00%    
Number of shares returned for cancellation   14,465,259    
Series A-1 Supermajority Voting Preferred Stock [Member] | Mr. Gerard Dab [Member]        
Restructuring Cost and Reserve [Line Items]        
Number of shares issued on acquisition   1,000    
Number of shares exchanged   $ 300,000    
Voting percent   51.00%    
Series C-1 Convertible Redeemable Preferred Stock [Member] | Mr. Gerard Dab [Member]        
Restructuring Cost and Reserve [Line Items]        
Number of shares issued on acquisition   200    
Number of shares exchanged   $ 200,000    
Fair market value of shares   $ 122,000    
Rennova Health Inc. [Member] | Series B-1 Convertible Redeemable Preferred Stock [Member]        
Restructuring Cost and Reserve [Line Items]        
Number of shares issued 14,000   950  
Stated value per share $ 1,000      
Percentage of shares for conversion 4.99%      
Number of shares issued 14,950      
Fair market value of common stock $ 9,086,396